References
-
1
Winawer S J, Fletcher R H, Miller L, Godlee F, Stolar M H, Mulrow C D, Woolf S H, Glick S N, Ganiats T G, Bond J H, et al.
Colorectal cancer screening - clinical guidelines and rationale (1997; 112: 594).
Gastroenterology.
1997;
112
1060-1063
-
2 Parkin D M, Whelan S L, Ferlay J, Raymond L, Young J. International Agency for Research on Cancer. WHO and International Association of cancer registries (eds) Cancer incidence in five continents. Lyon; VII. IARC Scientific Publications 1997 143
-
3
Cooper G S, Yuan Z, Landefeld C S, Johanson J F, Rimm A A.
A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans.
Cancer.
1995;
75
775-781
-
4
Capocaccia R, De Angelis R, Frova L, Gatta G, Sant M, Micheli A, Berrino F, Conti E, Gafa L, Roncucci L, et al.
Estimation and projections of colorectal cancer trends in Italy.
Int J Epidemiol.
1997;
26
924-932
-
5
Vader J P, Burnand B, Froehlich F, Dubois R W, Bochud M, Gonvers J J.
The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods.
Endoscopy.
1999;
31
572-578
-
6
Vader J P, Froehlich F, Dubois R W, Beglinger C, Wietlisbach V, Pittet V, Ebel N, Gonvers J J, Burnand B.
The European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site.
Endoscopy.
1999;
31
687-694
-
7
Bochud M, Burnand B, Froehlich F, Dubois R W, Vader J P, Gonvers J J.
Appropriateness of colonoscopy: Surveillance after curative resection of colorectal cancer.
Endoscopy.
1999;
31
664-671
-
8
Ahlquist D A, Wieand H S, Moertel C G, McGill D B, Loprinzi C L, O'Connell M J, Mailliard J A, Gerstner J B, Pandya K, Ellefson R D.
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
JAMA.
1993;
269
1262-1267
-
9
Allison J E, Tewaka I S, Ransom L J, Adrain A L.
A comparison of fecal occult-blood tests for colorectal-cancer screening.
N Engl J Med.
1996;
334
155-159
-
10
Ransohoff D F, Lang C A.
Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening.
Ann Intern Med.
1997;
126
808-810
-
11
Ransohoff D F, Lang C A.
Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
Ann Intern Med.
1997;
126
811-822
-
12
Kronborg O, Fenger C, Olsen J, Jorgensen O D, Sondergaard O.
randomized study of screening for colorectal cancer with faecal-occult-blood test.
Lancet.
1996;
348
1467-1471
-
13
Mandel J S, Bond J H, Church T R, Snover D C, Bradley G M, Schuman L M, Ederer F.
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study.
N Engl J Med.
1993;
328
1365-1371
-
14
Hardcastle J D, Chamberlain J O, Robinson M H, Moss S M, Amar S S, Balfour T W, James P D, Mangham C M.
randomized controlled trial of fecal-occult-blood screening for colorectal cancer.
Lancet.
1996;
348
1472-1477
-
15
Selby J V, Friedman G D, Quesenberry C P, Weiss N S.
Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control-study.
Ann Intern Med.
1993;
118
1-6
-
16
Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, Aisawa T, Yoshida Y.
Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study.
Int J Cancer.
1995;
61
465-469
-
17
Wahrendorf J, Robra B P, Wiebelt H, Oberhausen R, Weiland M, Dhom G.
Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
Eur J Cancer Prev.
1993;
2
221-227
-
18
Launoy G, Herbert C, Vallee J P, Desoubeaux N, Reaud J M, Ollivier V, Bouvier V, Flachs A, Arsene D, Valla A, et al.
Mass screening for colorectal cancer in France. Experience in 165 000 people in the department of Calvados (French).
Gastroenterol Clin Biol.
1996;
20
228-236
-
19
Pitsch R J, Becker J M, Dayton M T.
The occurrence of colon cancer in patients with known premalignant colonic mucosal diseases.
Journal of Surgical Research.
1994;
57
293-298
-
20
Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C.
Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial.
Dis Colon Rectum.
1994;
37
115-119
-
21
Tazi M A, Faivre J, Dassonville F, Lamour J, Milan C, Durand G.
Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996.
J Med Screen.
1997;
4
147-151
-
22
Sommer T, Kronborg O.
Possible causes of a positive haemoccult-ii test in a population screening study for colorectal neoplasia.
Eur J Cancer Prev.
1996;
5
181-187
-
23
Vernon S W.
Adherence to colorectal cancer screening. A brief overview (review, 19 refs).
Annals of the New York Academy of Sciences.
1995;
768
292-295
-
24
Myers R E, Balshem A M, Wolf T A, Ross E A, Millner L.
Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation.
American Journal of Public Health.
1993;
83
1620-1622
-
25 U.S.P.S.T.F .Screening for Colorectal Cancer in “Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force”. Baltimore; USPSTF 1996 2: 89
-
26
Solomon M J, McLeod R S.
Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
Canadian Medical Association Journal.
1994;
150
1961-1970
-
27
Winawer S J, Zauber A G, Ho M N, O'Brien M J, Gottlieb L S, Sternberg S S, Waye J D, Schapiro M, Bond J H, Panish J F, et al.
Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup.
N Engl J Med.
1993;
329
1977-1981
-
28
Rockey D CKJCJPSLLMK.
Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
New England Journal of Medicine.
1998;
339
153-159
-
29
Fine K D.
The prevalence of occult gastrointestinal bleeding in celiac sprue (see comments).
New England Journal of Medicine.
1996;
334
1163-1167
-
30
Schnell T, Aranha G V, Sontag S J, Tode R, Reid S, Chejfec G, Karpf J, Levine G.
Fecal occult blood testing: a false sense of security?.
Surgery.
1994;
116
798-803
-
31
Lang C A, Ransohoff D F.
Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?.
JAMA.
1994;
271
1011-1013
-
32
Bond J H.
Screening for colorectal cancer: confuting the refuters.
Gastrointest Endosc.
1997;
45
105-109
-
33
Dubow R A, Katon R M, Benner K G, van Dijk C M, Koval G, Smith F W.
Short (35 cm) vs. long (60 cm) flexible sigmoidoscopy: a comparison of findings and tolerance in asymptomatic patients screened for colorectal neoplasia.
Gastrointest Endosc.
1985;
31
305-308
-
34
Wilking N, Petrelli N J, Herrera Ornelas L, Walsh D, Mittelman A.
A comparison of the 25 cm rigid proctosigmoidoscope with the 65 cm flexible endoscope in the screening of patients for colorectal carcinoma.
Cancer.
1986;
57
669-671
-
35
Neugut A I, Forde K A.
Screening colonoscopy: has the time come?.
Am J Gastroenterol.
1988;
83
295-297
-
36
Foutch P G, Mai H, Pardy K, DiSario J A, Manne R K, Kerr D.
Flexible sigmoidoscopy may be the ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men.
Dig Dis Sci.
1991;
36
924-928
-
37
Wherry D C, Thomas W M.
The yield of flexible fiberoptic sigmoidoscopy in the detection of asymptomatic colorectal neoplasia.
Surg Endosc.
1984;
8
393-395
-
38
Olynyk J K, Aquilia S, Fletcher D R, Dickinson J A.
Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project.
Med J Aust.
1996;
165
74-76
-
39
Hoff G, Sauar J, Vatn M H, Larsen S, Langmark F, Moen I E, Foerster A, Thiis-Evensen E.
Polypectomy of adenomas in the prevention of colorectal cancer. 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study.
Scan J Gastroenterol.
1996;
31
1006-1010
-
40
Reilly J M, Ballantyne G H, Fleming F X, Zucker K A, Modlin I M.
Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
Am Surg.
1990;
56
119-123
-
41
Lieberman D A, Smith F W.
Screening for colon malignancy with colonoscopy.
Am J Gastroenterol.
1991;
86
946-951
-
42
Jensen J, Kewenter J, Asztely M, Lycke G, Wojciechowski J.
Double contrast barium enema and flexible rectosigmoidoscopy: a reliable diagostic combination for detection of colorectal neoplasm.
Br J Surg.
1990;
77
270-272
-
43
Selby J V, Friedman G D, Quesenberry C P, Weiss N S.
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.
N Engl J Med.
1992;
326
653-657
-
44
Newcomb P A, Norfleet R G, Storer B E, Surawicz T S, Marcus P M.
Screening sigmoidoscopy and colorectal cancer mortality (see comments).
Journal of the National Cancer Institute.
1992;
84
1572-1575
-
45
Muller A D, Sonnenberg A.
Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32 702 veterans (see comments).
Ann Intern Med.
1995;
123
904-910
-
46
Selby J V, Friedman G D, Collen M F.
Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study.
J Clin Epidemiol.
1988;
41
427-434
-
47
Atkin W S, Morson B C, Cuzick J.
Long-term risk of colorectal cancer after excision of rectosigmoid adenomas (see comments).
N Engl J Med.
1992;
326
658-662
-
48
Brint S L, DiPalma J A, Herrera J L.
Colorectal cancer screening: is one-year surveillance sigmoidoscopy necessary?.
Am J Gastroenterol.
1993;
88
2019-2021
-
49
Rex D K, Lehmann G A, Ulbright T M, Smith J J, Hawes R H.
The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination.
Gastroenterology.
1994;
106
593-595
-
50
Lewis S F, Jensen N M.
Screening sigmoidoscopy. Factors associated with utilization (see comments).
Journal of General Internal Medicine.
1996;
11
542-544
-
51
Senore C, Segnan N, Rossini F P, Ferraris R, Cavallero M, Coppola F, Pennazio M, Atkin W S.
Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy.
J Med Screen.
1996;
3
72-78
-
52
Schroy P C, Wilson S, Afdhal N.
Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system.
Am J Gastroenterol.
1996;
91
1331-1337
-
53
Atkin W S, Cuzick J, Northover J M, Whynes D K.
Prevention of colorectal cancer by once-only sigmoidoscopy.
Lancet.
1993;
341
736-740
-
54
Atkin W S, Hart A, Edwards R, Mcintyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover J A.
Uptake yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening.
Gut.
1998;
42
560-565
-
55
Winawer S J, St John D J, Bond J H, Rozen P, Burt R W, Waye J D, Kronborg O, O'Brien M J, Bishop D T, Kurtz R C, et al.
Prevention of colorectal cancer: guidelines based on new data. WHO collaborating center for the prevention of colorectal cancer.
Bulletin of the World Health Organization.
1995;
73
7-10
-
56
Eddy D M.
Screening of colorectal cancer.
Ann Intern Med.
1990;
113
373-384
-
57
Rex D K, Rahmani E Y, Haseman J H, Lemmel G T, Kaster S, Buckley J S.
Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clincial practice.
Gastroenterology.
1997;
112
17-23
-
58
Kewenter J, Brevinge H, Engaras B, Haglind E.
The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive hemoccult test.
Endoscopy.
1995;
27
159-163
-
59
Toribara N W, Sleisenger M H.
Screening for colorectal cancer.
N Engl J Med.
1995;
332
861-867
-
60
Gelfand D W, Ott D J.
The economic implications of radiologic screening for colonic cancer.
AJR.
1991;
156
939-943
-
61
Rex D K.
Colonoscopy: a review of its yield for cancers and adenomas by indication.
Am J Gastroenterol.
1995;
90
353-365
-
62
Johnson D A, Gurney M S, Volpe R J, Jones D M, VanNess M M, Chobanian S J, Avalos J C, Buck J L, Kooyman G, Cattau E LJ.
A prospective study of the prevalance of colonic neoplasms in asymptomatic patients with an age-related risk.
Am J Gastroenterol.
1990;
85
969-974
-
63
Rex D K, Lehman G A, Hawes R H, Ulbright T M, Smith J J.
Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests.
Gastroenterology.
1991;
100
64-67
-
64
Guillem J G, Forde K A, Treat M R, Neugut A I, O'Toole K M, Diamond B E.
Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study.
Dis Colon Rectum.
1992;
35
523-529
-
65
Hixson L J, Fennerty M B, Sampliner R E, Garewal H S.
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps.
Gastrointest Endosc.
1991;
37
125-127
-
66
Rogge J D, Elmore M F, Mahoney S J, Brown E D, Troiano F P, Wagner D R, Black D J, Pound D C.
Low-cost, office-based, screening colonoscopy (see comments).
Am J Gastroenterol.
1994;
89
1775-1780
-
67
Bochud M, Burnand B, Froehlich F, Dubois R W, Vader J P, Gonvers J J.
Appropriateness of colonoscopy: Surveillance after polypectomy.
Endoscopy.
1999;
31
654-663
-
68
Froehlich F, Larequi-Lauber T, Gonvers J J, Dubois R W, Burnand B, Vader J P.
Appropriateness of colonoscopy: Inflammatory bowel disease.
Endoscopy.
1999;
31
647-653
-
69
Sauar J, Hausken T, Hoff G, Bjorkheim A, Foerster A, Mowinckel P.
Colonoscopic screening examiantion of relatives of patients with colorectal cancer. I. A comparison with an endoscopically screened normal population.
Scan J Gastroenterol.
1992;
27
661-666
-
70
Rex D K, Lehman G A, Ulbright T M, Smith J J, Pound D C, Hawes R H, Helper D J, Wiersema M J, Langefeld C D, Li W.
Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
Am J Gastroenterol.
1993;
88
825-831
-
71
Brewer D A, Fung C L, Chapuis P H, Bokey E L.
Should relatives of patients with colorectal cancer be screened? A critical review of the literature.
Dis Colon Rectum.
1994;
37
1328-1338
-
72
Colombo L, Corti G, Magri F, Marocchi A, Brambilla P, Crespi C, Manieri L, Ghezzi S, Giannone D, Merlino L, et al.
Results of a pilot study of endoscopic screening for first degree relatives of colorectal cancer patients in Italy.
Journal of Epidemiology & Community Health.
1997;
51
453-458
-
73
Lynch H T, Smyrk T, Lynch J, Fitzgibbons R J, Lanspa S, McGinn T.
Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer.
Eur J Cancer.
1995;
31A (7 - 8)
1039-1046
-
74
Jarvinen H J, Mecklin J P, Sistonen P.
Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer (see comments).
Gastroenterology.
1995;
108
1405-1411
-
75
Vasen H F, Mecklin J P, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen L B, Cristofaro G, Muller H, Khan P M, et al.
Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC.
Dis Colon Rectum.
1993;
36
1-4
-
76
Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, Kahn M J, McTiernan A, Offit K, Thomson E, et al.
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer genetics studies consortium.
JAMA.
1997;
277
915-919
-
77
Simon J B.
Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.
N Engl J Med.
1998;
338
1151-1152
-
78
Brevinge H, Lindholm E, Buntzen S, Kewenter J.
Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55 - 56 years old population.
Int J Colorectal Dis.
1997;
12
291-295
1 The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE, Lausanne, Switzerland)
Dr. Bernard Burnand
IUMSP
Bugnon 17
CH-1005 Lausanne
Switzerland
Telefon: + 41-21-3144954
eMail: Bernard.Burnand@inst.hospvd.ch
